Hemispherx Biopharma Inc

Hemispherx Biopharma Inc

Health CarePharmaceuticals & Biotechnology
  • Price (USD)0.3253
  • Today's Change-0.0047 / -1.42%
  • Shares traded387.15k
  • 1 Year change-62.18%
  • Beta-0.9291
Data delayed at least 15 minutes, as of Dec 12 2017 19:47 GMT.
More ▼

Events & Activity

  • HEB:ASQ price falls below 50-day moving average to 0.3213 at 09:31 GMT
  • HEB:ASQ price moved over +2.08% to 0.3295
  • HEB:ASQ trading volume exceeds daily average by +16.24%
  • HEB:ASQ price rises above 50-day moving average to 0.3245 at 09:30 GMT
  • HEB:ASQ price falls below 15-day moving average to 0.3252 at 09:31 GMT
  • HEB:ASQ price falls below 15-day moving average to 0.326 at 15:33 GMT
  • HEB:ASQ price rises above 15-day moving average to 0.3295 at 09:36 GMT

Key statistics

As of last trade Hemispherx Biopharma Inc (HEB:ASQ) traded at 0.3253, 8.43% above its 52-week low of 0.300, set on Nov 02, 2017.
52-week range
0.300Nov 02 20170.93Jan 17 2017
Markit short selling activity
Previous close0.33
Average volume950.73k
Shares outstanding31.87m
Free float30.47m
P/E (TTM)--
Market cap10.52m USD
EPS (TTM)-0.2818
Data delayed at least 15 minutes, as of Dec 12 2017 19:47 GMT.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.